Medicine
Akynzeo 300 mg/0.5 mg capsule
Akynzeo 300 mg/0.5 mg capsule is a prescription medicine containing Netupitant and Palonosetron for oral use, marketed by Helsinn Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store AKYNZEO for injection in carton, protected from light at 2° to 8°C (35.6…
Key facts
- Active ingredient (INN)
- Netupitant and Palonosetron
- Brand
- Akynzeo
- Strength
- 300 mg/0.5 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 1 blister pack, 2 blister pack
- Marketing authorisation holder
- Helsinn Therapeutics
- Manufacturer
- Helsinn Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store AKYNZEO for injection in carton, protected from light at 2° to 8°C (35.6 F to 46.4°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A04AA Anti-nausea and anti-vomiting medicines, subgroup A04A, subgroup A04AA
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 October 2014
- Identifiers
- RxCUI 1552343, 1552349, 2044429 +3DailyMed set ID 8e47618e-af46-4d82-94e8-1507c042252dNDC 69639-101Application NDA205718
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 blister pack in 1 carton / 1 capsule in 1 blister pack | 69639-101-01 | Helsinn Therapeutics | 13 October 2014 |
| 2 blister pack in 1 carton / 2 capsule in 1 blister pack | 69639-101-04 | Helsinn Therapeutics | 13 October 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Netupitant and Palonosetron is a fixed-dose combination of a serotonin-3 receptor antagonist and a substance P/neurokinin-1 receptor antagonist. It is available as capsules for oral use. MedsAcross supplies Netupitant and Palonosetron for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Netupitant and PalonosetronFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- AKYNZEO prescribing information (Helsinn Therapeutics) · U.S. National Library of Medicine, DailyMed
- Akynzeo: European public assessment report (EPAR) · European Medicines Agency
Need Akynzeo 300 mg/0.5 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.